ArticleCancer discovery2024

Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts.

Timothy P DiPeri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.